Japan Steroid Injections Market Size & Growth Rate
According to 6Wresearch internal database and industry insights, the Japan Steroid Injections Market was valued at USD 199 Million in 2025 and is projected to reach USD 330 Million by 2032, growing at a CAGR of approximately 7.5% during 2026–2032.
Japan Steroid Injections Market Highlights
| Report Metric | Details |
| Report Name | Japan Steroid Injections Market (2026-2032) |
| Market Size 2025 | USD 199 Million |
| Market Size 2032 | USD 330 Million |
| Absolute Growth 2025–2032 | USD 131 Million |
| CAGR 2026–2032 | 7.5% |
| Peak Annual Growth | 8.0% in 2028 |
| Forecast Period | 2026–2032 |
| Historical Data | 2022–2025 |
| Base Year | 2025 |
| Leading Product Type, 2025 | Triamcinolone (39% share) |
| Leading Route of Administration, 2025 | Intra-Articular (39% share) |
| Leading Distribution Channel, 2025 | Hospital Pharmacy (45% share) |
| Fastest-Growing Product Type | Prednisolone (10.6% CAGR) |
| Fastest-Growing Route of Administration | Intramuscular (9.6% CAGR) |
| Fastest-Growing Distribution Channel | Specialty Clinics (9.7% CAGR) |
| Growing Sector | Healthcare |
| Key End Users | Hospitals, Specialty Clinics, Emergency Rooms, Healthcare Providers |
Japan Steroid Injections Market Year-wise Growth Rate and Key Drivers (2022–2032)
This graph illustrates the annual growth rates of the market from 2022 to 2032, highlighting a steady upward trajectory and projected market expansion over the forecast period.
Year by year, the estimates below pair each growth rate with the development that shaped it.
| Year | Estimated Annual Growth (%) | Market Rationale |
| 2022 | 4.2 | The market experienced steady growth due to consistent demand from healthcare providers. |
| 2023 | 4.5 | Growth accelerated as hospitals increased their use of steroid injections for various treatments. |
| 2024 | 3.0 | Growth slowed slightly as healthcare facilities adjusted to new treatment protocols. |
| 2025 | 3.8 | Demand rose again as more patients sought treatment for chronic conditions. |
| 2026 | 7.9 | Investment in healthcare infrastructure is anticipated to spur a rise in steroid usage. |
| 2027 | 7.4 | Growth is projected to moderate as the market adjusts to the influx of new treatments. |
| 2028 | 8.0 | The peak growth rate is anticipated due to heightened awareness of steroid benefits. |
| 2029 | 7.5 | Growth is expected to slow as market saturation begins to affect new patient intake. |
| 2030 | 7.6 | Demand is projected to increase again as new treatment guidelines are widely adopted. |
| 2031 | 6.3 | Growth is expected to moderate as healthcare providers focus on cost management strategies. |
| 2032 | 7.8 | The market is projected to grow as access to treatments improves. |
Note: Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary forecasting methodology, utilizing the latest available industry data, government publications, and primary research inputs.
Japan Steroid Injections Market Synopsis
Steroid injections are pharmaceutical preparations containing corticosteroids, primarily used to reduce inflammation and suppress the immune response. The Japan Steroid Injections Market is experiencing growth driven by increasing demand from healthcare providers and hospitals, particularly in urban centres like Tokyo. The introduction of new treatment protocols and a government programme aimed at improving access to essential medications are further stimulating demand.
Market Dynamics Impact Analysis (2026–2032)
| Factor | Type | Impact | Primary Segment Affected |
| Rising prevalence of chronic inflammatory conditions | Driver | High | Prednisolone |
| Increased investment in healthcare infrastructure | Driver | High | Hospital Pharmacy |
| Expansion of specialty clinics | Opportunity | High | Specialty Clinics |
| Growing patient awareness of treatment options | Opportunity | Medium | Intra-Articular |
| Regulatory challenges in drug approval processes | Restraint | High | Methylprednisolone |
| Limited access to certain medications in rural areas | Restraint | Medium | Prednisone |
| High costs associated with advanced treatment technologies | Challenge | High | Intravenous |
| Competition from alternative therapies | Challenge | Medium | Epidural |
Evaluation of Drivers in Japan Steroid Injections Market (2026–2032)
These are the developments adding the most demand over the forecast period.
| Drivers | Primary Segment Affected | Why It Matters (Evidence) |
| Increased prevalence of chronic diseases | Prednisolone | This drives demand as more patients seek steroid injections for conditions like COPD, with approximately 3 million diagnosed annually. |
| Investment in healthcare facilities | Hospital Pharmacy | This leads to more hospitals offering steroid treatments, with Tokyo being a major hub for healthcare services. |
| Rising number of specialty clinics | Specialty Clinics | The increase of 15% in rheumatology clinics improves access to steroid injections for targeted treatments. |
| Growing acceptance of steroid therapies | Intra-Articular | This acceptance is reflected in treatment protocols recommended by the Japan Society of Allergology. |
| Emergency room protocols for acute reactions | Methylprednisolone | Frequent use in emergency settings drives demand, particularly for acute allergic reactions. |
Most of the extra volume comes from the rising prevalence of chronic diseases, which increases demand for steroid injections. Approximately 3 million people are diagnosed with chronic obstructive pulmonary disease annually, leading to higher prescriptions of Prednisolone. Investment in healthcare facilities is also on the rise, particularly in urban areas where hospitals are expanding their treatment offerings. The growth of specialty clinics, which have increased by 15% over the last decade, improves patient access to targeted steroid therapies. Emergency room protocols frequently utilise Methylprednisolone for acute allergic reactions, driving demand for these injections.
Evaluation of Restraints in Japan Steroid Injections Market
These restraints slow adoption and weigh on supplier margins.
| Market Restraint | Primary Segment Affected | Why It Matters (Evidence) |
| Regulatory challenges in drug approval processes | Methylprednisolone | These challenges can delay the introduction of new steroid therapies, affecting availability for patients. |
| Limited access to certain medications in rural areas | Prednisone | Patients in rural regions may struggle to obtain necessary treatments, resulting in unmet medical needs. |
| High costs associated with advanced treatment technologies | Intravenous | Such costs can deter hospitals from adopting new technologies, restricting patient access to effective treatments. |
| Competition from alternative therapies | Epidural | Alternative pain management options can divert patients from steroid treatments, impacting market share. |
| Stringent quality standards for pharmaceutical manufacturing | Triamcinolone | Compliance with ISO 9001 standards can increase production costs, affecting pricing strategies. |
Japan Steroid Injections Market Challenges
High technology costs for pharmaceutical manufacturing reach up to 20% of total production expenses, limiting producers' ability to upgrade equipment. Stringent regulations from the Ministry of Health, Labour and Welfare can delay product approvals by six months for hospitals, hindering timely access to new therapies. Intense competition from alternative treatments forces hospitals to lower prices, which can reduce profit margins by 15% for steroid injections. A shortage of specialised medical staff complicates treatment delivery, resulting in increased hospital readmission rates by 10% for patients requiring steroid therapies.
Trends in the Japan Steroid Injections Market
The trends below show where the Japan Steroid Injections Market is heading.
- Shift towards Intra-Articular Administration: The trend towards Intra-Articular administration is gaining traction, especially for joint inflammation treatments. This method allows for localized effects, reducing systemic side effects. In 2022, approximately 39% of steroid injections were administered this way, reflecting a growing preference among healthcare providers.
- Increase in Specialty Clinics: The rise of specialty clinics is transforming the provision of steroid treatments. With a 15% increase in rheumatology clinics over the last decade, more patients are accessing targeted therapies. This shift is expected to improve treatment outcomes and patient satisfaction.
- Focus on Emergency Room Protocols: Emergency rooms are increasingly adopting standardized protocols for steroid use, particularly Methylprednisolone for acute allergic reactions. In 2023, hospitals reported a 20% increase in the use of this steroid in emergency settings, enhancing patient care.
- Expansion of Patient Education Programs: Patient education programs are becoming more prevalent, aimed at increasing awareness of steroid therapies. The Japan Society of Allergology has initiated campaigns to inform patients about the benefits and risks, contributing to a more informed patient base.
Investment Opportunities in the Japan Steroid Injections Market
The opportunities below stand out in the Japan Steroid Injections Market for new entrants and existing suppliers.
- Steroid Injections for Chronic Conditions: There is a growing opportunity to supply steroid injections for chronic conditions, particularly in urban areas. With 3 million people diagnosed with COPD, healthcare providers are seeking effective treatment options.
- Investment in Specialty Clinics: The timing is ideal to invest in specialty clinics, with a projected growth rate of 9.7% for this segment. By establishing partnerships with local healthcare providers, suppliers can strengthen their market presence.
- Expansion of Hospital Pharmacy Services: With hospital pharmacies holding a 45% market share, there is a significant gap in providing comprehensive steroid treatment options. Investing in these services can meet increasing patient demand.
- Improving Access to Medications: The recent government programme aims to improve access to essential medications, creating opportunities for suppliers. Engaging with healthcare facilities to ensure compliance can facilitate market entry.
Government Initiatives in the Japan Steroid Injections Market
The regulation of steroid injections in Japan is influenced by several key laws. The Medical Care Act of 1948 establishes standards for hospitals and clinics, ensuring quality care. More recently, the Clinical Trials Act of 2017 sets rules for the conduct of clinical research, impacting how new steroid therapies are developed and tested. These frameworks ensure that healthcare providers adhere to stringent quality and safety standards.
The Pharmaceuticals and Medical Devices Agency (PMDA) is responsible for reviewing pharmaceuticals and medical devices, including steroid injections. This agency monitors post-market safety and ensures that new treatments are safe for public use. Additionally, the Japan Agency for Medical Research and Development (AMED) funds medical research and development, supporting innovations in steroid therapies.
Future Insight of the Japan Steroid Injections Market
The investment pipeline in advanced manufacturing technologies will create demand for improved production processes by 2032, benefiting suppliers and enhancing market efficiency. A government programme aimed at improving access to essential medications will broaden the market for steroid injections, providing more options for healthcare providers. Updated guidelines from the Japan Society of Allergology will streamline treatment protocols, leading to better patient outcomes. The growth of specialty clinics for rheumatology will further increase demand for steroid injections, improving accessibility for patients.
Market Segmentation Analysis
Japan Steroid Injections Market report covers a detailed analysis of the following market segments:
By Product Type – Triamcinolone Leads, Prednisolone Expected to Grow Fastest
According to Summon Dutta, Assistant Manager at 6Wresearch, Triamcinolone took 39% of product type revenue in 2025, more than any other category. Triamcinolone holds the largest share due to its common use in treating joint inflammation, particularly in hospitals and clinics throughout Japan. Its established role in treatment protocols ensures it remains a preferred choice among healthcare providers. Prednisolone is projected to grow fastest, at a CAGR of 10.6% during 2026–2032. Prednisolone is experiencing rapid growth as it is widely prescribed for various inflammatory conditions, indicating a rise in awareness and diagnosis of such ailments. The increasing number of patients with chronic inflammatory diseases contributes to its growing prescription rates. This trend suggests that suppliers should focus on improving the availability of Prednisolone to meet the rising demand.
By Route of Administration – Intra-Articular Leads, Intramuscular Expected to Grow Fastest
In 2025, Intra-Articular led the route of administration split with a 39% share. Intra-Articular administration leads the market as it provides targeted relief for joint-related issues, particularly in urban centres like Tokyo where healthcare services are concentrated. This method is favoured for its effectiveness in reducing inflammation directly at the site of pain. The quickest growth will come from Intramuscular, forecast to expand at a CAGR of 9.6% between 2026 and 2032. Intramuscular administration is growing quickly due to its versatility in treating a range of conditions, appealing to both healthcare providers and patients. The increasing number of specialty clinics adopting this method contributes to its rapid uptake. Suppliers must ensure adequate training and resources for healthcare providers to optimise the use of Intramuscular injections.
By Distribution Channel – Hospital Pharmacy Leads, Specialty Clinics Expected to Grow Fastest
Hospital Pharmacy accounted for 45% of the market by distribution channel in 2025. Hospital Pharmacy holds the largest share as it is the primary distribution point for steroid injections in hospitals, which are crucial for treating various medical conditions. The extensive use of these injections in facilities like Tokyo's healthcare centres underscores the importance of hospital pharmacies in patient care. Specialty Clinics are set to record the highest CAGR in this split, 9.7% over 2026–2032. Specialty Clinics are experiencing the fastest growth due to their targeted approach in treating specific conditions that require steroid injections. The 15% increase in the number of these clinics over the last decade highlights a growing preference for specialised healthcare services. This suggests that suppliers should strategically engage with specialty clinics to enhance their distribution capabilities.
Key Attractiveness of the Report
- 10 Years of Market Numbers
- Historical Data Starting from 2022 to 2025
- Base Year 2025
- Forecast Data until 2032
- Key Performance Indicators Impacting the Market
- Major Upcoming Developments and Projects
Key Highlights of the Report:
- Japan Steroid Injections Market Outlook
- Market Size of Japan Steroid Injections Market, 2025
- Forecast of Japan Steroid Injections Market, 2032
- Historical Data and Forecast of Japan Steroid Injections Revenues & Volume for the Period 2022-2032
- Japan Steroid Injections Market Trend Evolution
- Japan Steroid Injections Market Drivers and Challenges
- Japan Steroid Injections Price Trends
- Japan Steroid Injections Porter's Five Forces
- Japan Steroid Injections Industry Life Cycle
- Historical Data and Forecast of Japan Steroid Injections Market Revenues & Volume By Product Type for the Period 2022-2032
- Historical Data and Forecast of Japan Steroid Injections Market Revenues & Volume By Triamcinolone for the Period 2022-2032
- Historical Data and Forecast of Japan Steroid Injections Market Revenues & Volume By Prednisolone for the Period 2022-2032
- Historical Data and Forecast of Japan Steroid Injections Market Revenues & Volume By Methylprednisolone for the Period 2022-2032
- Historical Data and Forecast of Japan Steroid Injections Market Revenues & Volume By Prednisone for the Period 2022-2032
- Historical Data and Forecast of Japan Steroid Injections Market Revenues & Volume By Dexamethasone for the Period 2022-2032
- Historical Data and Forecast of Japan Steroid Injections Market Revenues & Volume By Route of Administration for the Period 2022-2032
- Historical Data and Forecast of Japan Steroid Injections Market Revenues & Volume By Intra-Articular for the Period 2022-2032
- Historical Data and Forecast of Japan Steroid Injections Market Revenues & Volume By Intramuscular for the Period 2022-2032
- Historical Data and Forecast of Japan Steroid Injections Market Revenues & Volume By Intravenous for the Period 2022-2032
- Historical Data and Forecast of Japan Steroid Injections Market Revenues & Volume By Epidural for the Period 2022-2032
- Historical Data and Forecast of Japan Steroid Injections Market Revenues & Volume By Distribution Channel for the Period 2022-2032
- Historical Data and Forecast of Japan Steroid Injections Market Revenues & Volume By Hospital Pharmacy for the Period 2022-2032
- Historical Data and Forecast of Japan Steroid Injections Market Revenues & Volume By Specialty Clinics for the Period 2022-2032
- Historical Data and Forecast of Japan Steroid Injections Market Revenues & Volume By Retail Pharmacy and Drug Stores for the Period 2022-2032
- Historical Data and Forecast of Japan Steroid Injections Market Revenues & Volume By Others for the Period 2022-2032
- Japan Steroid Injections Import Export Trade Statistics
- Market Opportunity Assessment By Product Type
- Market Opportunity Assessment By Route of Administration
- Market Opportunity Assessment By Distribution Channel
- Japan Steroid Injections Top Companies Market Share
- Japan Steroid Injections Competitive Benchmarking By Technical and Operational Parameters
- Japan Steroid Injections Company Profiles
- Japan Steroid Injections Key Strategic Recommendations
Market Covered
Coverage by segment is as follows.
By Product Type
- Triamcinolone
- Prednisolone
- Methylprednisolone
- Prednisone
- Dexamethasone
By Route of Administration
- Intra-Articular
- Intramuscular
- Intravenous
- Epidural
By Distribution Channel
- Hospital Pharmacy
- Specialty Clinics
- Retail Pharmacy and Drug Stores
- Others







